Skip to content

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03942952
Acronym
SONICS
Enrollment
49
Registered
2019-05-08
Start date
2019-10-22
Completion date
2023-06-30
Last updated
2023-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Disseminated Encephalomyelitis, Multiple Sclerosis, Relapsing-Remitting, Neuromyelitis Optica, Transverse Myelitis

Keywords

Multiple Sclerosis, NMO, anti-MOG, Acute Disseminated Encephalolmyelitis

Brief summary

Central Nervous System (CNS) demyelinating conditions include multiple sclerosis (MS), Acute Disseminated Encephalomyelitis (ADEM), Neuromyelitis Optica Spectrum Disorder (NMOSD), Optic Neuritis (ON) and Transverse Myelitis (TM). The symptoms of these conditions are quite variable from patient to patient, but can include motor, sensory, visual, gait and cognitive changes. Conventional MRI can be used to look for new anatomic changes, but fails to measure underlying biochemical changes in brain tissue. The purposes of this study are to identify the biologic and anatomic correlations between cognitive profiles and disease activity using MRI imaging techniques.

Detailed description

Pediatric patients (age 12 to 21 inclusive) with a diagnosis of multiple sclerosis, ADEM, anti-MOG mediated demyelinating disease as well as healthy controls will be recruited to undergo clinical testing. The study visits will include neuropsychological testing, optical coherence tomography (OCT) and MRI on both the 3T and 7T magnet. Subjects will be asked to undergo two study visits separated by 12 months to 18 months. Each study visit will have the same neuropsychological, OCT, and research MRI examinations.

Interventions

None listed

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

1. Diagnosis of Multiple Sclerosis , ADEM, anti-MOG antibody associated CNS demyelination 2. Age 12 to 21 inclusive at time of enrollment 3. Ability of parent or legal guardian to provide informed consent if participant is under 18. 4. Ability of patients age 12-17 to give assent 5. Completion of the signed HIPPA authorization form by a parent or legal guardian or by participants (18 years of age).

Exclusion criteria

1. Known history of traumatic brain injury that required medical care 2. Non-English speaking (based on standardized neuropsychological testing and questionnaires) 3. Claustrophobic, the presence of metallic braces, implants or medical devices that are unsafe at 3T or 7T and/or interfere with the MRI/MRS signals

Design outcomes

Primary

MeasureTime frameDescription
Change in Score of Conners Continuous Performance Test 3rd Edition10-14 monthsSustained Attention and Behavioral Inhibition
Change in Score of WISC-V or WAIS-IV Digits Backward10-14 monthsWorking Memory
Change in Score of California Verbal Learning Test- Children's Version (CVLT-C) or California Verbal Learning Test-Second Edition (CVLT-II)10-14 monthsVerbal Learning and Memory
Change i Score of D-KEFS Letter and Category Fluency10-14 monthsVerbal Fluency
Change in Score of WASI-II10-14 monthsEstimate of IQ
Change in Score of Woodcock-Johnson Tests of Achievement Letter Word identification10-14 monthsBasic Reading Skill
Change in Score of Reading Fluency10-14 monthsReading Speed
Change in Score of Calculation10-14 monthsMath Calculation Skills
Change in Score of Math Fluency10-14 monthsMath Speed
Change in Score of Word Attack10-14 monthsPhoneme/Grapheme Knowledge
Change in Score of Grooved Pegboard10-14 monthsBilateral Fine Motor Speed and Dexterity
Change in Score of Trail Making Test, Part A and B10-14 monthsSimple and complex Attention
MRI Brain without contrast10-14 months3T MRI
Change in Score of Delis-Kaplan Executive Function System (D-KEFS) Color10-14 monthsExecutive Functioning
Change in Score of Word Interference Test (CWIT)10-14 monthsExecutive Functioning
Change in Score of Symbol Digit Modalities (SDMT)- Oral Version10-14 monthsProcessing Speed
Change in Score of Beery-Buktencia Developmental Test of Visual-Motor Integration, Sixth Edition (VMI-6)10-14 monthsVisual-Motor Integration
Change in Score of Wechsler Intelligence Scale for Children-5th edition (WISCV)10-14 monthsSimple Auditory Attention
Change in Score of Wechsler Adult Intelligence Scale-Fourth edition (WAIS-IV) Digits Forward10-14 monthsSimple Auditory Attention

Secondary

MeasureTime frameDescription
Change in PROMIS Mobility score10-14 monthsPatient Reported Outcomes Measures: Mobility, walking
Change in PROMIS Pain score10-14 monthsPatient Reported Outcomes Measures: overall pain level
Change in PROMIS Peer relationship score10-14 monthsPatient Reported Outcomes Measures: Peer relationships
Change in PROMIS Stress score10-14 monthsPatient Reported Outcomes Measures: Psychological stress
Change in PROMIS Upper extremity movement score10-14 monthsPatient Reported Outcomes Measures: Upper extremity movement
Change in score of 25 foot timed walk10-14 monthsWalking speed
Change in score of 6 minute timed walk10-14 monthsWalking Distance
Change in score of Hauser Ambulation Index10-14 monthsFunctional walking assessment
Change in score of Multiple Sclerosis Functional Capacity (MSFC)10-14 monthsHand and Eye coordination, Memory test
Change in score of Modified Rankin Scale10-14 monthsDisability scale
Change in Examination of Optical Coherence Tomography10-14 monthsEye examination

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026